Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients

NCT03226691 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

NIH

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Plerixafor

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborators

[object Object]